Quantcast

Latest Diabetes mellitus type 1 Stories

2014-02-12 08:28:24

Clinical program focused on reversing type 1 diabetes symptoms in patients diagnosed within six months of trial initiation EDGEWATER, N.J. and SAN DIEGO, Feb. 12, 2014 /PRNewswire/ -- DiaVacs, Inc., a clinical stage biotechnology company focused on developing cell-based therapy for treatment of type 1 diabetes, and Profil(® )Institute for Clinical Research, Inc., an early phase clinical research organization focused on diabetes and obesity, announced today a strategic collaboration...

2014-02-11 12:27:38

The Biggest Loser RunWalk and The Biggest Loser Resorts Will Sponsor 5K Race at Annual Event Which Raises Funds for Diabetes Research Institute MIAMI, Feb. 11, 2014 /PRNewswire-USNewswire/ -- The Diabetes Research Institute Foundation has once again teamed up with Walgreens, the nation's largest drugstore chain, for the DRI Walk for Diabetes & Family Fun Day. This marquee event along with The Biggest Loser RunWalk 5K will be held the morning of Saturday, March 8, 2014 at Sun Life...

2014-02-11 08:32:23

LA CHAUX-DE-FONDS, Switzerland, February 11, 2014 /PRNewswire/ -- Kareus Therapeutics SA ("Kareus") announced today that US FDA has approved its Investigational New Drug (IND) KU-5039 to initiate Phase I clinical trial. KU 5039 is being developed for the treatment of insulin resistance and diabetes. KU-5039 is an orally active, New Chemical Entity (NCE), discovered and developed by Kareus. KU-5039 is a potent and selective activator of AMP-kinase (AMPK), a key...

2014-02-10 12:25:17

JERUSALEM, Feb. 10, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it has submitted a protocol to the U.S. Food and Drug Administration (FDA) to initiate a Phase 2a trial of its orally ingestible insulin capsule, ORMD 0801, for type 1 diabetes. The protocol was submitted under Oramed's existing IND for ORMD-0801 to include both...

2014-02-07 13:00:08

Insulin use to treat type 2 diabetes trebles over 20 years "Understanding the pattern of insulin use is limited by a lack of data characterizing the prevalence of insulin use in the UK," according to Craig Currie, Professor of Applied Pharmacoepidemiology at Cardiff University's School of Medicine, who led the study alongside colleagues from the University of Bristol. "Given the limitations, our study sought to calculate – for the first time – the best possible estimate of the rates...

2014-02-06 23:23:31

Filmmakers Dan Finegold and Josh Eisenfeld have teamed with scientist and producer Dr. Dan Handley on a groundbreaking documentary that will chronicle the quest for what may be the first preventative therapy for Type 1 diabetes. Pittsburgh, PA (PRWEB) February 06, 2014 Official Project Website Type 1 diabetes affects over three million Americans, and is particularly devastating for the high proportion of children it afflicts. The disease is a type of autoimmune disorder where the body’s...

2014-02-06 23:02:31

Niche Publishing Leader Now Offers Five Wellness Titles BOSTON, MA (PRWEB) February 06, 2014 Madavor Media, LLC a specialty media company and one of the publishing industry’s fastest-growing providers of niche consumer content, has acquired Diabetic CookingTM magazine, which exclusively addresses diabetes control through dietary management and simple, healthful, recipes. This acquisition adds a fifth title to Madavor Media’s rapidly expanding Wellness division, which grew...

2014-02-06 08:29:38

-- Potentially transformative therapy for individuals with type 1 diabetes nearing major milestone -- NEW YORK and SAN DIEGO, Feb. 6, 2014 /PRNewswire/ -- JDRF, the world's largest non-profit supporter of type 1 diabetes (T1D) research, and ViaCyte, Inc., a leading regenerative medicine company, jointly announced that JDRF is providing additional milestone-based funding for the continued development of ViaCyte's VC-01(TM) encapsulated cell therapy product candidate for the treatment...

2014-02-06 04:21:32

SAN DIEGO, Feb. 6, 2014 /PRNewswire/ -- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® Insulin Pump, today presented the results of a research study that demonstrated faster training times and fewer errors when using the t:slim Pump versus a leading insulin pump. These data were presented at the 7(th) Annual Advanced Technologies and Treatments for Diabetes (ATTD) International Conference in Vienna, Austria. (Logo:...

2014-01-31 16:24:02

Diabetes Online Community Encourages Public to Support International Diabetes Federation's Life for a Child Program BERKELEY, Calif., Jan. 31, 2014 /PRNewswire-iReach/ -- One rose, one month of life. A dozen roses, a year of life for a child with diabetes. (Photo: http://photos.prnewswire.com/prnh/20140131/MN56922) For the second consecutive year, the Diabetes Hands Foundation, is joining with the Diabetes Online Community (DOC) to encourage people to buy one less rose this...


Latest Diabetes mellitus type 1 Reference Libraries

Diabetes (journal)
2012-05-12 21:44:48

Diabetes is a peer-reviewed medical journal published since 1952 by the American Diabetes Association. Diabetes is a separate journal from the journal Diabetes Care, which is also published by the ADA. Diabetes covers research about the physiology and pathophysiology of diabetes mellitus, including any aspect of laboratory, animal or human research. Emphasis is on investigative reports focusing on areas such as the pathogenesis of diabetes and its complications, normal and pathologic...

More Articles (1 articles) »
Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related